nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—urine—urinary bladder cancer	0.00663	0.247	CbGeAlD
Esomeprazole—ATP4A—epithelium—urinary bladder cancer	0.00501	0.187	CbGeAlD
Esomeprazole—ATP4A—renal system—urinary bladder cancer	0.00464	0.173	CbGeAlD
Esomeprazole—CYP3A4—urine—urinary bladder cancer	0.00392	0.146	CbGeAlD
Esomeprazole—ATP4A—female reproductive system—urinary bladder cancer	0.00372	0.139	CbGeAlD
Esomeprazole—CYP2C19—vagina—urinary bladder cancer	0.00117	0.0438	CbGeAlD
Esomeprazole—CYP3A4—renal system—urinary bladder cancer	0.000959	0.0358	CbGeAlD
Esomeprazole—CYP3A4—female reproductive system—urinary bladder cancer	0.000768	0.0286	CbGeAlD
Esomeprazole—Jaundice—Doxorubicin—urinary bladder cancer	0.000493	0.000506	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—urinary bladder cancer	0.000491	0.000505	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—urinary bladder cancer	0.000491	0.000505	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—urinary bladder cancer	0.000491	0.000505	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000491	0.000505	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000491	0.000505	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—urinary bladder cancer	0.00049	0.000504	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—urinary bladder cancer	0.00049	0.000503	CcSEcCtD
Esomeprazole—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00049	0.000503	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—urinary bladder cancer	0.000488	0.000502	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000488	0.000501	CcSEcCtD
Esomeprazole—Asthenia—Cisplatin—urinary bladder cancer	0.000487	0.0005	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—urinary bladder cancer	0.000487	0.0005	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000484	0.000497	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000483	0.000496	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—urinary bladder cancer	0.000482	0.000495	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000482	0.000495	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000481	0.000494	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000478	0.000491	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000477	0.00049	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—urinary bladder cancer	0.000474	0.000487	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000473	0.000486	CcSEcCtD
Esomeprazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000473	0.000486	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—urinary bladder cancer	0.000472	0.000485	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000472	0.000485	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000472	0.000485	CcSEcCtD
Esomeprazole—Chills—Methotrexate—urinary bladder cancer	0.00047	0.000483	CcSEcCtD
Esomeprazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000464	0.000477	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000464	0.000476	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—urinary bladder cancer	0.000463	0.000476	CcSEcCtD
Esomeprazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000463	0.000475	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000462	0.000475	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—urinary bladder cancer	0.000459	0.000472	CcSEcCtD
Esomeprazole—Rash—Gemcitabine—urinary bladder cancer	0.000459	0.000471	CcSEcCtD
Esomeprazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000458	0.000471	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—urinary bladder cancer	0.000458	0.000471	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.000458	0.00047	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—urinary bladder cancer	0.000457	0.00047	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000456	0.000469	CcSEcCtD
Esomeprazole—Headache—Gemcitabine—urinary bladder cancer	0.000456	0.000468	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—urinary bladder cancer	0.000455	0.000468	CcSEcCtD
Esomeprazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000455	0.000467	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—urinary bladder cancer	0.000455	0.000467	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—urinary bladder cancer	0.000454	0.000466	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000451	0.000464	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—urinary bladder cancer	0.000451	0.000464	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000451	0.000463	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00045	0.000463	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—urinary bladder cancer	0.000448	0.000461	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000448	0.00046	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000447	0.000459	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000447	0.000459	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—urinary bladder cancer	0.000446	0.000458	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000446	0.000458	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000445	0.000457	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000443	0.000455	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000442	0.000454	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—urinary bladder cancer	0.000441	0.000453	CcSEcCtD
Esomeprazole—Chills—Epirubicin—urinary bladder cancer	0.00044	0.000452	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—urinary bladder cancer	0.00044	0.000452	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—urinary bladder cancer	0.000437	0.000449	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—urinary bladder cancer	0.000433	0.000445	CcSEcCtD
Esomeprazole—Nausea—Gemcitabine—urinary bladder cancer	0.000432	0.000444	CcSEcCtD
Esomeprazole—Vomiting—Cisplatin—urinary bladder cancer	0.000431	0.000443	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—urinary bladder cancer	0.00043	0.000442	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—urinary bladder cancer	0.00043	0.000441	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000429	0.000441	CcSEcCtD
Esomeprazole—Rash—Cisplatin—urinary bladder cancer	0.000428	0.000439	CcSEcCtD
Esomeprazole—Dermatitis—Cisplatin—urinary bladder cancer	0.000427	0.000439	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—urinary bladder cancer	0.000427	0.000439	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—urinary bladder cancer	0.000425	0.000437	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—urinary bladder cancer	0.000425	0.000437	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—urinary bladder cancer	0.000424	0.000436	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000423	0.000435	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—urinary bladder cancer	0.000423	0.000435	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—urinary bladder cancer	0.000422	0.000433	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—urinary bladder cancer	0.000421	0.000433	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—urinary bladder cancer	0.000421	0.000432	CcSEcCtD
Esomeprazole—Tension—Epirubicin—urinary bladder cancer	0.000419	0.00043	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—urinary bladder cancer	0.000418	0.000429	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—urinary bladder cancer	0.000415	0.000426	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—urinary bladder cancer	0.000413	0.000424	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—urinary bladder cancer	0.000411	0.000423	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—urinary bladder cancer	0.000411	0.000422	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—urinary bladder cancer	0.00041	0.000422	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00041	0.000421	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—urinary bladder cancer	0.00041	0.000421	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000409	0.00042	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—urinary bladder cancer	0.000408	0.000419	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—urinary bladder cancer	0.000407	0.000418	CcSEcCtD
Esomeprazole—Nausea—Cisplatin—urinary bladder cancer	0.000403	0.000414	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—urinary bladder cancer	0.000402	0.000413	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—urinary bladder cancer	0.000401	0.000412	CcSEcCtD
Esomeprazole—Cough—Methotrexate—urinary bladder cancer	0.000398	0.000409	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—urinary bladder cancer	0.000397	0.000408	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000396	0.000407	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—urinary bladder cancer	0.000395	0.000406	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000395	0.000406	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—urinary bladder cancer	0.000394	0.000405	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—urinary bladder cancer	0.000392	0.000403	CcSEcCtD
Esomeprazole—Rash—Etoposide—urinary bladder cancer	0.000392	0.000403	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—urinary bladder cancer	0.000391	0.000402	CcSEcCtD
Esomeprazole—Headache—Etoposide—urinary bladder cancer	0.000389	0.0004	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—urinary bladder cancer	0.000389	0.0004	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—urinary bladder cancer	0.000388	0.000399	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—urinary bladder cancer	0.000388	0.000399	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—urinary bladder cancer	0.000388	0.000399	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—urinary bladder cancer	0.000388	0.000398	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000387	0.000397	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000386	0.000396	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—urinary bladder cancer	0.000385	0.000395	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—urinary bladder cancer	0.000384	0.000394	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—urinary bladder cancer	0.000384	0.000394	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—urinary bladder cancer	0.000383	0.000394	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—urinary bladder cancer	0.000382	0.000393	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—urinary bladder cancer	0.000382	0.000392	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00038	0.00039	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—urinary bladder cancer	0.000377	0.000388	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—urinary bladder cancer	0.000375	0.000386	CcSEcCtD
Esomeprazole—Cough—Epirubicin—urinary bladder cancer	0.000372	0.000383	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000372	0.000382	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—urinary bladder cancer	0.000372	0.000382	CcSEcCtD
Esomeprazole—Infection—Methotrexate—urinary bladder cancer	0.00037	0.00038	CcSEcCtD
Esomeprazole—Nausea—Etoposide—urinary bladder cancer	0.000369	0.000379	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—urinary bladder cancer	0.000368	0.000379	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000366	0.000376	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000365	0.000375	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—urinary bladder cancer	0.000365	0.000375	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000364	0.000374	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—urinary bladder cancer	0.000363	0.000373	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—urinary bladder cancer	0.000363	0.000373	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—urinary bladder cancer	0.000363	0.000373	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—urinary bladder cancer	0.000363	0.000373	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—urinary bladder cancer	0.000362	0.000372	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—urinary bladder cancer	0.000362	0.000371	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000361	0.000371	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00036	0.00037	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—urinary bladder cancer	0.000359	0.000369	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—urinary bladder cancer	0.000356	0.000366	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—urinary bladder cancer	0.000355	0.000365	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—urinary bladder cancer	0.000355	0.000365	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—urinary bladder cancer	0.000355	0.000365	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000353	0.000363	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—urinary bladder cancer	0.000351	0.000361	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—urinary bladder cancer	0.000349	0.000359	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000348	0.000358	CcSEcCtD
Esomeprazole—Infection—Epirubicin—urinary bladder cancer	0.000346	0.000356	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—urinary bladder cancer	0.000345	0.000354	CcSEcCtD
Esomeprazole—Shock—Epirubicin—urinary bladder cancer	0.000343	0.000352	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000342	0.000351	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000341	0.00035	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—urinary bladder cancer	0.000341	0.00035	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—urinary bladder cancer	0.00034	0.000349	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000339	0.000348	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—urinary bladder cancer	0.000338	0.000348	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000337	0.000346	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—urinary bladder cancer	0.000337	0.000346	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—urinary bladder cancer	0.000336	0.000345	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—urinary bladder cancer	0.000336	0.000345	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—urinary bladder cancer	0.000336	0.000345	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—urinary bladder cancer	0.000335	0.000344	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000334	0.000343	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000334	0.000343	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—urinary bladder cancer	0.000332	0.000341	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—urinary bladder cancer	0.000332	0.000341	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—urinary bladder cancer	0.000332	0.000341	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—urinary bladder cancer	0.000331	0.00034	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—urinary bladder cancer	0.000329	0.000338	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000328	0.000337	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—urinary bladder cancer	0.000325	0.000334	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000324	0.000332	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000322	0.000331	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000321	0.00033	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—urinary bladder cancer	0.000321	0.00033	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—urinary bladder cancer	0.00032	0.000329	CcSEcCtD
Esomeprazole—Pain—Methotrexate—urinary bladder cancer	0.000318	0.000327	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000317	0.000326	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—urinary bladder cancer	0.000317	0.000326	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000316	0.000325	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000316	0.000324	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—urinary bladder cancer	0.000315	0.000324	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—urinary bladder cancer	0.000315	0.000323	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000313	0.000322	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000313	0.000321	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000312	0.00032	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—urinary bladder cancer	0.000311	0.000319	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—urinary bladder cancer	0.00031	0.000318	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—urinary bladder cancer	0.000307	0.000316	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000307	0.000315	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000307	0.000315	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000304	0.000313	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000303	0.000311	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000301	0.000309	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—urinary bladder cancer	0.0003	0.000309	CcSEcCtD
Esomeprazole—Pain—Epirubicin—urinary bladder cancer	0.000298	0.000306	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—urinary bladder cancer	0.000298	0.000306	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—urinary bladder cancer	0.000296	0.000304	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000294	0.000302	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000294	0.000302	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000294	0.000302	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—urinary bladder cancer	0.000291	0.0003	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000289	0.000297	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000287	0.000295	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000287	0.000295	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—urinary bladder cancer	0.000287	0.000294	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000285	0.000293	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000284	0.000292	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00028	0.000288	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000278	0.000286	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—urinary bladder cancer	0.000278	0.000286	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—urinary bladder cancer	0.000277	0.000284	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—urinary bladder cancer	0.000276	0.000283	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—urinary bladder cancer	0.000276	0.000283	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000275	0.000283	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000275	0.000283	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000274	0.000282	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—urinary bladder cancer	0.000267	0.000274	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000266	0.000273	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000264	0.000271	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—urinary bladder cancer	0.000263	0.000271	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000257	0.000264	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—urinary bladder cancer	0.000256	0.000263	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000255	0.000262	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000255	0.000262	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000255	0.000262	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—urinary bladder cancer	0.00025	0.000257	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—urinary bladder cancer	0.000246	0.000253	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—urinary bladder cancer	0.000246	0.000253	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000238	0.000245	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000237	0.000244	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—urinary bladder cancer	0.000237	0.000243	CcSEcCtD
Esomeprazole—Rash—Methotrexate—urinary bladder cancer	0.000235	0.000241	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—urinary bladder cancer	0.000234	0.000241	CcSEcCtD
Esomeprazole—Headache—Methotrexate—urinary bladder cancer	0.000233	0.00024	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—urinary bladder cancer	0.000231	0.000238	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—urinary bladder cancer	0.00023	0.000237	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—urinary bladder cancer	0.000228	0.000234	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—urinary bladder cancer	0.000221	0.000228	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—urinary bladder cancer	0.000221	0.000227	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000221	0.000227	CcSEcCtD
Esomeprazole—Rash—Epirubicin—urinary bladder cancer	0.00022	0.000226	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—urinary bladder cancer	0.000219	0.000225	CcSEcCtD
Esomeprazole—Headache—Epirubicin—urinary bladder cancer	0.000218	0.000224	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—urinary bladder cancer	0.000213	0.000219	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—urinary bladder cancer	0.000207	0.000213	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—urinary bladder cancer	0.000205	0.000211	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—urinary bladder cancer	0.000203	0.000209	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000203	0.000209	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—urinary bladder cancer	0.000202	0.000207	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—urinary bladder cancer	0.000191	0.000197	CcSEcCtD
